142 related articles for article (PubMed ID: 1597543)
1. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.
Saiag P; Caumes E; Chosidow O; Revuz J; Roujeau JC
J Am Acad Dermatol; 1992 Apr; 26(4):567-74. PubMed ID: 1597543
[TBL] [Abstract][Full Text] [Related]
2. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
[TBL] [Abstract][Full Text] [Related]
3. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
4. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.
Belfort R; de Smet M; Whitcup SM; Pavesio C; Lottenberg C; Rubin B; Lopez JS; Nussenblatt R
Cornea; 1991 Nov; 10(6):536-8. PubMed ID: 1782783
[TBL] [Abstract][Full Text] [Related]
5. Evolving pattern of drug-induced toxic epidermal necrolysis.
Correia O; Chosidow O; Saiag P; Bastuji-Garin S; Revuz J; Roujeau JC
Dermatology; 1993; 186(1):32-7. PubMed ID: 8435514
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
[TBL] [Abstract][Full Text] [Related]
7. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
[TBL] [Abstract][Full Text] [Related]
8. Oral manifestations of toxic epidermal necrolysis (TEN) in patients with AIDS: report of five cases.
Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
Oral Dis; 1998 Jun; 4(2):90-4. PubMed ID: 9680896
[TBL] [Abstract][Full Text] [Related]
9. HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital.
Tseng J; Maurer T; Mutizwa MM
J Int Assoc Provid AIDS Care; 2017; 16(1):37-41. PubMed ID: 26685211
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
11. [Lyell's syndrome in 2 HIV infected patients. Sulfamides are not the only culprits].
Rosenthal E; Bodokh I; Chichmanian RM; Pesce A; Vinti H; Reboulot B; Cassuto JP
Presse Med; 1991 Sep; 20(30):1459. PubMed ID: 1835037
[No Abstract] [Full Text] [Related]
12. Drug-induced Lyell and Stevens-Johnson syndromes.
Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
[TBL] [Abstract][Full Text] [Related]
13. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
14. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
[TBL] [Abstract][Full Text] [Related]
15. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins.
Tan A; Tan HH; Lee CC; Ng SK
Clin Exp Dermatol; 2003 May; 28(3):269-71. PubMed ID: 12780710
[TBL] [Abstract][Full Text] [Related]
16. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
Devarbhavi H; Raj S; Aradya VH; Rangegowda VT; Veeranna GP; Singh R; Reddy V; Patil M
Hepatology; 2016 Mar; 63(3):993-9. PubMed ID: 26439084
[TBL] [Abstract][Full Text] [Related]
18. [Vemurafenib-induced toxic epidermal necrolysis].
Wantz M; Spanoudi-Kitrimi I; Lasek A; Lebas D; Quinchon JF; Modiano P
Ann Dermatol Venereol; 2014 Mar; 141(3):215-8. PubMed ID: 24635957
[TBL] [Abstract][Full Text] [Related]
19. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
